NEW YORK (GenomeWeb News) – BioFire Diagnostics today said that Athyrium Opportunities Fund increased its investment in the company to $45 million.

Athyrium invested $25 million into BioFire in September. The new financing will go toward continued commercialization of and to meet growing demand for the Salt Lake City-based company's FilmArray molecular diagnostic platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.